Thursday, September 24, 2020
Home Health Top Health News Zydus Cadila gets tentative USFDA nod to market anti-cancer drug

Zydus Cadila gets tentative USFDA nod to market anti-cancer drug


Zydus Cadila gets tentative USFDA nod to market anti-cancer drugDrug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules. Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg, 100 mg, and 125 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.

Palbociclib is an anti-cancer medicine that interferes with the growth and spread of cancer cells in the body. The company said the newly approved medication will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad.

The group now has 302 approvals and has so far filed over 390 abbreviated new drug applications since the commencement of the filing process in financial year 2003-04. Shares of Cadila Healthcare were trading 1.07 per cent lower at Rs 379.80 on BSE.

- Advertisement -

Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules.


Source
- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Kamala Harris stars in new comic book birthday gift

The cover of “Female Force: Kamala Harris”, part of Tidalwave Productions’ Political Power series, featuring Kamala Harris, chronicling her path from childhood to...

India’s ShareChat raises $40 million from investors including Twitter, Lightspeed

A man watches a movie on his phone as he waits for the bank to open to exchange his old high-denomination banknotes in...

Trump calls FDA plan to tighten guidelines for COVID-19 vaccine approval ‘political move’

Washington: US President Donald Trump on Wednesday (local time) said that his administration may or may not approve a proposal from the Food...

Ayushmann Khurrana becomes youngest Indian to feature in ‘TIME’s 100 MOST INFLUENTIAL PEOPLE OF 2020’

Bollywood actor Ayushmann Khurrana, the youngest person to be featured on TIME magazine’s 100 Most Influenctial People List Sept. 22, 2020. (Photo: Instagram...

Recent Comments